"Health Information Technology System (Roadmap 2.0) in the Context of Hematopoietic Cell Transplantation"

NACompletedINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

September 8, 2020

Primary Completion Date

August 11, 2024

Study Completion Date

August 11, 2024

Conditions
Hematologic Diseases
Interventions
OTHER

Wearable activity sensor

Caregivers and patients in both arms of the study will have a Fitbit wearable activity sensor to track activity and sleep.

BEHAVIORAL

Roadmap 2.0 information system

Caregivers and patients download the Roadmap 2.0 app on their mobile phones or tablets

OTHER

Survey administration

Caregivers and patients will be asked to respond to survey questions at 3 timepoints.

BEHAVIORAL

Roadmap 2.0 information system with Positive Activities

Caregivers and patients download the Roadmap 2.0 app on their mobile phones. Caregivers and patients will be instructed on how to operate Roadmap 1.0 on an iPad (inpatient only) and Roadmap 2.0 on a mobile phone (inpatient and outpatient). Caregivers download the Positive Activities app onto their mobile phone to use freely throughout inpatient and outpatient (through day 120 post-transplant). Caregiver may also use an electronic tablet provided by the study team during the patient's hospital stay.

Trial Locations (2)

48109

University of Michigan Rogel Cancer Center, Ann Arbor

97239

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

Department of Health and Human Services

FED

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Michigan Rogel Cancer Center

OTHER

NCT04094844 - "Health Information Technology System (Roadmap 2.0) in the Context of Hematopoietic Cell Transplantation" | Biotech Hunter | Biotech Hunter